Literature DB >> 3840838

Detection of 5-S-cysteinyldopamine in human brain.

E Rosengren, E Linder-Eliasson, A Carlsson.   

Abstract

5-S-Cysteinyldopamine was synthesized and used as reference compound in HPLC analyses of extracts from various regions of human brain. The compound could be detected in brain regions rich in dopamine (caudate nucleus, putamen, globus pallidus and substantia nigra) but not in other regions (cerebellum, occipital cortex). The occurrence of 5-S-cysteinyldopamine in dopaminergic brain regions supports the hypothesis that dopamine in part undergoes autoxidation, leading to formation of highly reactive quinones. The newly discovered metabolite may prove useful in future studies of dopamine autoxidation and the possibly resultant cytotoxicity in aging and degenerative brain disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840838     DOI: 10.1007/bf01252029

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  7 in total

1.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

2.  Genetic toxicity of dopamine.

Authors:  P Moldéus; M Nordenskjöld; G Bolcsfoldi; A Eiche; U Haglund; B Lambert
Journal:  Mutat Res       Date:  1983-10       Impact factor: 2.433

3.  5-S-Cysteinyldopa in ganglion stellatum.

Authors:  C Fehling; C Hansson; J Poulsen; H Rorsman; E Rosengren
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

4.  Diastereomers of 5-S-cysteinyldopa.

Authors:  G Agrup; L E Edholm; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1983       Impact factor: 4.437

5.  5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.

Authors:  G Agrup; C Hansson; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

6.  Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.

Authors:  C Hansson; G Agrup; H Rorsman; E Rosengren
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

7.  Formation of cysteinyldopa from glutathionedopa in melanoma.

Authors:  G Agrup; B Falck; B M Kennedy; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1975       Impact factor: 4.437

  7 in total
  33 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Chemistry of periodate-mediated cross-linking of 3,4-dihydroxylphenylalanine-containing molecules to proteins.

Authors:  Bo Liu; Lyle Burdine; Thomas Kodadek
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

3.  Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.

Authors:  F C Cheng; J S Kuo; L G Chia; G Dryhurst
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.

Authors:  Carlos Cuevas; Sandro Huenchuguala; Patricia Muñoz; Monica Villa; Irmgard Paris; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2014-11-18       Impact factor: 3.911

5.  Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Authors:  Sandro Huenchuguala; Patricia Muñoz; Patricio Zavala; Mónica Villa; Carlos Cuevas; Ulises Ahumada; Rebecca Graumann; Beston F Nore; Eduardo Couve; Bengt Mannervik; Irmgard Paris; Juan Segura-Aguilar
Journal:  Autophagy       Date:  2014-01-14       Impact factor: 16.016

6.  Model neuromelanins as antioxidative agents during lipid peroxidation.

Authors:  T Wilczok; K Stepien; A Dzierzega-Lecznar; A Zajdel; A Wilczok
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

7.  The role of adrenochrome in stimulating the oxidation of catecholamines.

Authors:  A Bindoli; G Scutari; M P Rigobello
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

8.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

9.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

10.  Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.

Authors:  J F Marshall; S J O'Dell; F B Weihmuller
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.